CD34 and neoplasm: Morphometric analysis (Figure 5B) showed the significant increase of CD34+ into the tumor REL tissue (CD34: 0.51 ± 0.09%) as compared to the RESP samples, RESP (CD34: 0.2 ± 0.05%).